Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fecal transplantation for the treatment of Clostridium difficile infection.

Literature DB >> 22675283

Fecal transplantation for the treatment of Clostridium difficile infection.

Lawrence J Brandt¹.

Abstract

Entities: Disease Species

Year: 2012 PMID： 22675283 PMCID： PMC3365524

Source DB: PubMed Journal: Gastroenterol Hepatol (N Y) ISSN： 1554-7914

× No keyword cloud information.

6 in total

1. Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology.

Authors: Faith Rohlke; Christina M Surawicz; Neil Stollman
Journal: J Clin Gastroenterol Date: 2010-09 Impact factor: 3.062

2. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection.

Authors: Matthew J Hamilton; Alexa R Weingarden; Michael J Sadowsky; Alexander Khoruts
Journal: Am J Gastroenterol Date: 2012-01-31 Impact factor: 10.864

Review 3. Treating Clostridium difficile infection with fecal microbiota transplantation.

Authors: Johan S Bakken; Thomas Borody; Lawrence J Brandt; Joel V Brill; Daniel C Demarco; Marc Alaric Franzos; Colleen Kelly; Alexander Khoruts; Thomas Louie; Lawrence P Martinelli; Thomas A Moore; George Russell; Christina Surawicz
Journal: Clin Gastroenterol Hepatol Date: 2011-08-24 Impact factor: 11.382

4. Treatment of refractory/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients.

Authors: Sonia S Yoon; Lawrence J Brandt
Journal: J Clin Gastroenterol Date: 2010-09 Impact factor: 3.062

Review 5. Fecal microbiota transplantation for recurrent clostridium difficile infection.

Authors: Lawrence J Brandt; Sheela S Reddy
Journal: J Clin Gastroenterol Date: 2011-11 Impact factor: 3.062

6. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube.

Authors: Johannes Aas; Charles E Gessert; Johan S Bakken
Journal: Clin Infect Dis Date: 2003-02-14 Impact factor: 9.079

6 in total

21 in total

1. Chemical Genomics, Structure Elucidation, and in Vivo Studies of the Marine-Derived Anticlostridial Ecteinamycin.

Authors: Thomas P Wyche; René F Ramos Alvarenga; Jeff S Piotrowski; Megan N Duster; Simone R Warrack; Gabriel Cornilescu; Travis J De Wolfe; Yanpeng Hou; Doug R Braun; Gregory A Ellis; Scott W Simpkins; Justin Nelson; Chad L Myers; James Steele; Hirotada Mori; Nasia Safdar; John L Markley; Scott R Rajski; Tim S Bugni
Journal: ACS Chem Biol Date: 2017-07-26 Impact factor: 5.100

Fecal transplantation for the treatment of Clostridium difficile infection.

1. Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology.

2. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection.

Review 3. Treating Clostridium difficile infection with fecal microbiota transplantation.

4. Treatment of refractory/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients.

Review 5. Fecal microbiota transplantation for recurrent clostridium difficile infection.

6. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube.

1. Chemical Genomics, Structure Elucidation, and in Vivo Studies of the Marine-Derived Anticlostridial Ecteinamycin.

Review 2. Inflammation and colorectal cancer: colitis-associated neoplasia.

3. Leading From Darkness to Light: Understanding Chronic Disease and Coronavirus: An Integrative Perspective.

Review 4. Advances in Molecular Epidemiology of Infectious Diseases: Definitions, Approaches, and Scope of the Field.

Review 5. The microbiota and immune response during Clostridium difficile infection.

Review 6. The Use of Fecal Microbiome Transplant in Treating Human Diseases: Too Early for Poop?

Review 7. Consideration of Gut Microbiome in Murine Models of Diseases.

Review 8. Host genetic control of gut microbiome composition.

Review 9. Gut microbiota, probiotics, and human health.

10. Bile salt inhibition of host cell damage by Clostridium difficile toxins.